Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q1 2019 13F Holders as of 31 Mar 2019
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 162,897,398
- Total 13F value
- $5,472,194,669
- Share change
- -2,010,640
- Put/Call ratio
- 177%
- SEC-reported price per share
- $33.60
- Number of holders
- 340
- Value change
- -$66,824,317
- Number of buys
- 173
- Number of sells
- 133
- Shares outstanding
- 29,109,163
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2019
Institutions
340
Top holders
10
NKTR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Ownership snapshot
Top reported holders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2018
13F
Lead comparable stake: 89%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 89%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
89%
PRIMECAP MANAGEMENT CO/CA/
67%
VANGUARD GROUP INC
63%
OppenheimerFunds, Inc.
59%
BlackRock Finance, Inc.
45%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
89%
|
$853,355,000
25,961,520 shares
|
— | 31 Dec 2018 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
67%
|
$637,679,000
19,400,022 shares
|
— | 31 Dec 2018 |
| VANGUARD GROUP INC |
13F
Company
|
63%
|
$601,670,000
18,304,531 shares
|
— | 31 Dec 2018 |
| OppenheimerFunds, Inc. |
13F
Company
|
59%
|
$568,748,000
17,302,925 shares
|
— | 31 Dec 2018 |
| BlackRock Finance, Inc. |
13F
Company
|
45%
|
$426,626,000
12,979,178 shares
|
— | 31 Dec 2018 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
37%
|
$353,069,000
10,741,365 shares
|
— | 31 Dec 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
340
Shares
162,897,398
Rows available
340
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2019 vs Q1 2026 Across Filers
Q1 2026 holders
7
Q1 2019 holders
340
Holder diff
333
| Investor | Q1 2026 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend